Crawford Nomination Suggests Stability For Supplements, OTC Regulation
This article was originally published in The Tan Sheet
Executive Summary
Confirmation of Lester Crawford as permanent FDA commissioner would provide the consumer health industries with a known variable for at least the next four years
You may also be interested in...
US FDA Commissioner: Waiting Game Continues
The wait for a permanent head of FDA is continuing into the second year of the Biden administration. One message is coming through loud and clear: the agency is clearly not a top priority for the White House ... and that might be a good thing.
Crawford Must Answer “Tough Questions” During Confirmation – Grassley
Sen. Charles Grassley (R-Iowa) is noncommittal on the nomination of FDA Acting Commissioner Lester Crawford to fill the post on a permanent basis
FDA Plans To Reduce Field Labor Costs Using External Collaborations
FDA will use collaborative agreements to reduce its labor costs in field operations, Deputy Commissioner for Policy Amit Sachdev said during a recent AEI/Brookings Institute Joint Center for Regulatory Studies conference